News · 18 November 2026

Novartis reports nine cancer cases after its gene therapy Zolgensma

18 November 2026 · Health · Science · US

Novartis reports nine cancer cases after its gene therapy Zolgensma
Picture: MedPage Today · MedPage Today lead image · unknown

Novartis says nine people who got Zolgensma, its gene therapy for the muscle disease SMA, developed cancers. In two cases there was evidence its viral delivery tool had joined the patient's DNA. About 6,000 people have had the treatment. Regulators are reviewing the reports. Researchers have worried about this kind of risk for years.

Where this came from. 2 outlets reported this. We read them, then wrote the sixty words above.

Also on 18 November 2026